OPEN POSITION: Lead Software Engineer for C# / .NET (m/f)

We are seeking a highly talented and motivated Lead Software Engineer for C# / .NET (m/f) as our Lead Contributor to the core development team of the pharmaceutical modeling & simulation software “Open Systems Pharmacology Suite” …

OPEN POSITION: Systems Scientist Modeling & Simulation (m/f)

We are seeking a seeking a highly talented and motivated Systems Scientists Modeling & Simulation (m/f), keen on driving innovation and setting new boundaries in pharmacometrics & quantitative systems pharmacology …

esqLABS developing clinical decision support system

From within the „MoDiPro“ collaborations network, esqLABS & Partners have submitted a grant application for the GlucoSys Project. GlucoSys aims at developing a new technology solution for the control of blood glucose of intensive care patients in ICU wards…

esqLABS advancing OSPS

esqLABS is partnering with the Saarland University and the Bayer AG for the public-funding project OSMOSES to further develop the OPEN SOURCE software Open Systems Pharmacology Suite. The overall aim of the OSMOSES project is the further development of the “Open Systems…

News

esqLABS developing clinical decision support system

From within the „MoDiPro“ collaborations network, esqLABS & Partners have submitted a grant application for the GlucoSys Project. GlucoSys aims at developing a new technology solution for the control of blood glucose of intensive care patients in ICU wards…

esqLABS advancing OSPS

esqLABS is partnering with the Saarland University and the Bayer AG for the public-funding project OSMOSES to further develop the OPEN SOURCE software Open Systems Pharmacology Suite. The overall aim of the OSMOSES project is the further development of the “Open Systems…

UPCOMING Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

News ArchivE

OPEN POSITION: Lead Software Engineer for C# / .NET (m/f)

We are seeking a highly talented and motivated Lead Software Engineer for C# / .NET (m/f) as our Lead Contributor to the core development team of the pharmaceutical modeling & simulation software “Open Systems Pharmacology Suite” …

May 31, 2018: esqLABS and Sanofi present @ PAGE 2018

esqLABS is presenting with Sanofi-Aventis Deutschland GmbH about their work to advance the translational capabilities of the PB-QSP Diabetes platform by supporting M&S for preclinical species…

January 1, 2018, Pavel Balazki joins esqLABS

Pavel is an interdisciplinary scientist with a solid experience in physiological modeling and programming skills. He focuses on the combination of modeling and software development to offer QSP platforms as integrated solutions…

November 29, 2017: esqLABS joins MoDiPro

„MoDiPro“ delivers innovative „Industry 4.0“ concepts for the Biotech and Health Care Industries. Within the collaborations network, partners from industry and academia work on joint R&D projects to develop smart devices and predictive computer (simulation-) models for digital decision support systems…

June 22, 2017: esqLABS is founded

esqLABS GmbH is founded as a German Limited Liability Company and registered with the register of commerce in Oldenburg, Germany.

Past Events

October 7-11, 2018: esqLABS @ ACoP 2018

From October 7th to 11th, 2018, esqlabs will be @ ACoP 9 Meeting 2018 in San Diego, California. We will be presenting a poster on PB-QSP modeling in Diabetes for: PERSONALIZED MANAGEMENT…

October 17-19, 2018, esqLABS @ GMP 2018

esqLABS will be at the Annual Meeting of the Group of Metabolism and Pharmacokinetics in Paris, to discuss with  scientists from industry and academia bioanalytic, pharmacokinetic and metabolism studies and analyses on various areas of application. Dr. Stephan Schaller, CEO of esqLABS…

June 22-26, 2018: esqLABS is @ ADA 78th Scientific Sessions

esqlabs will be @ American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida. Reach out to us if you want to know how we can help you assess efficacy and outcome of novel Technology and Treatments in Diabetes using our PB-QSP Diabetes Platform.  ...

May 28 – June 1, 2018: esqLABS is @ PAGE Meeting 2018

esqLABS will be @ the PAGE Meeting in Montreux, Switzerland. We will be presenting two posters on PB-QSP modeling and give a workshop on “Integrating PBPK with QSP using PK-Sim and MoBi”. Reach out to us if you want to learn how you can leverage PB-QSP Platforms for...

October 6, 2018: OSPS Workshop @ ACoP 2018

esqLABS is running a one-day hands-on PK-Sim® & MoBi® workshop on integrating PBPK with QSP on Saturday October 6, 2018 at the Loews Coronado Bay Resort near San Diego, CA, United States…

March 21-24, 2018: esqLABS is @ ASCPT

esqlabs will be @ ASCPT Meeting 2018 in Orlando, Florida. Reach out to us if you want to know how we can help you assess efficacy and outcome of novel Technology and Treatments using PB-QSP Platforms…

May 28, 2018: OSPS Workshop @ PAGE 2018

esqLABS is running a one-day hands-on PK-Sim® & MoBi® workshop on integrating PBPK with QSP for in-silico first-in-man PD predictions on Monday 28 May at the Hotel Royal Plaza in Montreux, Switzerland as a Satellite meeting to PAGE 2018…

June 27, 2018: OSPS Workshop in BOSTON

esqLABS is running a one-day hands-on PK-Sim® & MoBi® workshop on integrating PBPK with QSP on Wednesday 27 June at the OFICIO Fenway Meeting Room in Boston, MA…

February 14-17, 2018: esqLABS is @ ATTD

esqlabs will be @ ATTD 2018 in Vienna, Austria. Reach out to us if you want to know how we can help you assess efficacy and outcome of novel Technology and Treatments in Diabetes using our PB-QSP Diabetes Platform.   esqLABS is @ ATTD From February 14th to 17th, 2018,...

Get in touch now

Contact

esqLABS GmbH | Hambierich 34 | 26683 Saterland | Germany
Tel. +49 151 / 58559070 | info@esqLABS.com